Details
- Manufacturer
- Vifor (International) Inc.
- ATC code
- G03DA04
- Status
- 9 abgeschlossen
- Reported since
- 106 days
- First report
- 9.10.2023
- Active substance
- progesteronum
- Swissmedic no.
- 4535105
- Public price (PPUB)
- CHF 16.40
- Ex-factory price (PEXF)
- CHF 6.73
- Product information (AIPS)
- swissmedicinfo.ch →
Overview
UTROGESTAN Kaps 100 mg 30 Stk is a medication by Vifor (International) Inc. containing the active substance progesteronum (ATC code G03DA04). This entry is marked as resolved — the documented shortage lasted 106 days. Shortages of this active substance in Switzerland have lasted on average 55 days (measured across 4 historical cases). Switzerland has 24 other products approved with the same active substance — none are currently available.
Available alternatives
No alternatives with the same active substance are currently available.
Composition
progesteronum 100 mg, helianthi oleum, lecithinum ex soja, Kapselhülle: gelatina, glycerolum, aqua purificata, E 171, pro capsula.
Historical history
This product (or one with the same active substance) has already been 4× in shortage.
Frequently asked questions
What can I do if UTROGESTAN Kaps 100 mg 30 Stk is unavailable?▾
Contact your pharmacy or treating physician. Substitution with a product containing the same active substance (progesteronum) is often possible. Available alternatives are listed above on this page.
What alternatives exist for UTROGESTAN Kaps 100 mg 30 Stk?▾
Available alternatives with the same active substance are listed above. progesteronum is the underlying active substance — pharmacies can dispense a generic or alternative brand after consulting with the doctor.
When will UTROGESTAN Kaps 100 mg 30 Stk be available again?▾
The expected delivery date — if communicated by the manufacturer — is shown in the detail section on this page. Shortages in this active-substance class typically last several weeks in Switzerland. Only the manufacturer can provide a binding forecast.
Why is UTROGESTAN Kaps 100 mg 30 Stk unavailable?▾
Common reasons include manufacturing problems, active-substance shortages, quality issues, or a planned withdrawal from the Swiss market. More detailed background — when disclosed by the manufacturer — is shown in the detail section above.
Where do I report a shortage of UTROGESTAN Kaps 100 mg 30 Stk?▾
Shortages are officially reported to drugshortage.ch (by manufacturers and pharmacies). Patients and treating physicians can escalate the shortage through their pharmacy — which has direct access to the reporting pipeline.
Source: drugshortage.ch · no warranty of completeness